Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$222K Buy
+5,426
New +$223K ﹤0.01% 1411
2025
Q4
Sell
-8,432
Closed -$319K 1540
2025
Q3
$319K Buy
+8,432
New +$313K ﹤0.01% 1287
2023
Q1
Sell
-417,759
Closed -$18.5M 1745
2022
Q4
$18.5M Buy
417,759
+388,557
+1,331% +$15.6M 0.27% 79
2022
Q3
$1.08M Buy
+29,202
New +$1.22M 0.01% 1077
2021
Q4
Sell
-7,937
Closed -$310K 2152
2021
Q3
$310K Buy
+7,937
New +$332K ﹤0.01% 1599
2020
Q4
Sell
-31,556
Closed -$1.08M 1952
2020
Q3
$1.08M Buy
+31,556
New +$1.14M 0.02% 654
2020
Q2
Sell
-12,633
Closed -$537K 1761
2020
Q1
$537K Buy
+12,633
New +$608K 0.03% 460

Other funds holding AVA

Michael Gelband's AVA Position: Q2 2026 in Review

Michael Gelband opened a new position in Avista (AVA) in Q2 2026: 5,426 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #1411 among its holdings. This is a return to the name: Michael Gelband previously reported a position in AVA as recently as Q3 2025.

Michael Gelband first reported a position in AVA in Q1 2020 and has held it in 7 quarters since. The position peaked at $18.5M in Q4 2022. 415 funds tracked by Wall St. Rank hold AVA as of Q2 2026.

  • Michael Gelband held 5,426 shares of Avista worth $222K as of Q2 2026.
  • Avista was a new Michael Gelband position in Q2 2026.
  • Avista made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1411 holding.
  • Michael Gelband first reported a position in Avista in Q1 2020 and has held it in 7 quarters since.
  • Michael Gelband's Avista position peaked at $18.5M in Q4 2022.
  • 415 funds tracked by Wall St. Rank held Avista as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.